![Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy manufacturing capacity](https://ala.associates/wp-content/uploads/2022/04/Yposkesi-GMP-suite_two-bioreactors-e1543329551661-500x250-1.jpg)
![Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant’s gene therapy manufacturing capacity](https://ala.associates/wp-content/uploads/2022/04/Yposkesi-GMP-suite_two-bioreactors-e1543329551661-500x250-1.jpg)
![Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringer Ingelheim](https://ala.associates/wp-content/uploads/2022/04/Pascal-NEUVILLE_DOMAIN-Therapeutics_portrait-1-500x250-1.png)
Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringer Ingelheim
![CardioRenal and the CEA sign multi-year partnership agreement to fine-tune telemedicine device](https://ala.associates/wp-content/uploads/2022/04/Heart-failure-measurement-device-Copyright-CEA-500x250-1.png)
CardioRenal and the CEA sign multi-year partnership agreement to fine-tune telemedicine device
![Precision medicine: Cap Digital and Medicen team up with Oncodesign, Servier and Intersystems](https://ala.associates/wp-content/uploads/2022/04/logo_Hu_PreciMED_FR-500x250-1.jpg)
Precision medicine: Cap Digital and Medicen team up with Oncodesign, Servier and Intersystems
![Inoviem Scientific enters into service-based partnership with XoNovo](https://ala.associates/wp-content/uploads/2022/04/inoviem-xonovo-e1536064791495-500x250-1.png)
Inoviem Scientific enters into service-based partnership with XoNovo
![Citoxlab signs investment and partnership deal with EPO](https://ala.associates/wp-content/uploads/2022/04/JF-Le-Bigot-e1535961123415-500x250-2.jpg)
Citoxlab signs investment and partnership deal with EPO
![Nosopharm renews its partnership with Inra](https://ala.associates/wp-content/uploads/2022/04/Nosopharm42-Investigating-Xenorhabdus-and-Photorhabdus-bacteria-500x250-1.jpg)
Nosopharm renews its partnership with Inra
![Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest](https://ala.associates/wp-content/uploads/2018/04/Michel-Feraud-Portrait-2-1080x675.jpg)
Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest
![Les sept pôles de compétitivité en santé français se constituent en réseau](https://ala.associates/wp-content/uploads/2018/04/pole-sante-e1523456602592-1080x431.jpeg)
Les sept pôles de compétitivité en santé français se constituent en réseau
![NovAliX’ clients can now access Pierre Fabre’s library of original fragments isolated from plants](https://ala.associates/wp-content/uploads/2018/03/Denis-Zeyer-e1522065118519-1080x675.jpg)